Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2025-12-17 @ 4:06 AM
Study NCT ID:
NCT06455462
Status:
None
Last Update Posted:
2025-10-22 00:00:00
First Post:
2024-03-01 00:00:00
Brief Title:
Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-22
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-01 00:00:00
First Submit QC Date:
June 11 2024
Study First Post Date:
2024-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-21 00:00:00
Last Update Post Date:
2025-10-22 00:00:00
Last Update Post Date Type:
ESTIMATED